Document Detail

Regulation of Expression and Function of IDO in Human Dendritic Cells.
MedLine Citation:
PMID:  21517757     Owner:  NLM     Status:  Publisher    
In the human immune system, IDO expression and activity (IDO competence), are preferentially found in the antigenpresenting cell population, of which dendritic cells (DCs) represent an essential part. As will be comprehensively reviewed, IDO competence in human DCs, in general, is induced by molecules such as interferon-γ, which otherwise initiate immunity. IDO activity therefore, can be interpreted as a negative feedback pathway that limits uncontrolled immune responses. Because of its potent immunosuppressive effects (down-regulation of T cell responses or the expansion of T cell regulatory activity), IDO competence in human DCs is tightly regulated, at the transcriptional, translational and post-translational levels. I will critically discuss the experimental prerequisites and limits of attributing IDO competence to a mechanism of immunosuppression and examine, whether IDO competence itself can be viewed as mediating immunosuppression, or as representing one component among other immunosuppressive factors, involved in tolerogenic function of DCs. Finally, the newly emerging concepts of manipulating IDO competence as a therapy for either augmenting immune responses, such as in cancer, or down-regulating immune responses, such as in transplantation, will be summarized.
A Heitger
Related Documents :
21132467 - Ambient ozone and pulmonary innate immunity.
21288827 - Concordance of ccr5 genotypes that influence cell-mediated immunity and hiv-1 disease p...
16912407 - Beneficial actions of hyaluronan (ha) on arthritic joints: effects of molecular weight ...
21088297 - Abscisic acid regulates inflammation via ligand-binding domain-independent activation o...
24486647 - Using glycan microarrays to understand immunity.
23095497 - Estradiol modulates tumor necrosis factor-induced endothelial inflammation: role of tum...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-4-26
Journal Detail:
Title:  Current medicinal chemistry     Volume:  -     ISSN:  1875-533X     ISO Abbreviation:  -     Publication Date:  2011 Apr 
Date Detail:
Created Date:  2011-4-26     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9440157     Medline TA:  Curr Med Chem     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Children's Cancer Research Institute, Div Transplantation Immunology, Zimmermannplatz 10, A-1090 Vienna, Austria.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Induction of Regulatory T Cells by Dendritic Cells through Indoleamine 2,3-dioxygenase: A Potent Mec...
Next Document:  Using an Ancient Tool for Igniting and Propagating Immune Tolerance: IDO as an Inducer and Amplifier...